Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

EEOC opens comment phase on Title II portion of GINA
March 2009
SHARING OPTIONS:

WASHINGTON, D.C.—The Genetic Information Non-Discrimination Act of 2008 (GINA) ushered in a new age for privacy and genomics, and now, as the Equal Employment Opportunity Commission prepares to implement GINA, it has opened a 60-day public comment phase for the employment rules in the act, or Title II.

Although many in the drug development world think it is unlikely that GINA will have a great impact on people's willingness to undergo genetic tests in genome-wide association studies or clinical trials involving genomics, some have suggested that clarification and improvement of GINA's protections might alleviate worries among some that their jobs could be jeopardized if they participate in such efforts.

Title II prohibits employers, employment companies and others from using genetic information when making certain decisions, including those about hiring and firing, and it prohibits them from intentionally acquiring and disseminating such genetic information. It also prohibits employers from requesting, requiring or purchasing such information except under certain circumstances.

Back



PAGE UTILITIES


CONTACT US
DDNEWS
1000 N West Street, Suite 1200,
Wilmington, Delaware, 19801
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.